Literature DB >> 29155708

Enrichment of Detergent-insoluble Protein Aggregates from Human Postmortem Brain.

Ian Diner1, Tram Nguyen1, Nicholas T Seyfried2.   

Abstract

In this study, we describe an abbreviated single-step fractionation protocol for the enrichment of detergent-insoluble protein aggregates from human postmortem brain. The ionic detergent N-lauryl-sarcosine (sarkosyl) effectively solubilizes natively folded proteins in brain tissue allowing the enrichment of detergent-insoluble protein aggregates from a wide range of neurodegenerative proteinopathies, such as Alzheimer's disease (AD), Parkinson's disease and amyotrophic lateral sclerosis, and prion diseases. Human control and AD postmortem brain tissues were homogenized and sedimented by ultracentrifugation in the presence of sarkosyl to enrich detergent-insoluble protein aggregates including pathologic phosphorylated tau, the core component of neurofibrillary tangles in AD. Western blotting demonstrated the differential solubility of aggregated phosphorylated-tau and the detergent-soluble protein, Early Endosome Antigen 1 (EEA1) in control and AD brain. Proteomic analysis also revealed enrichment of β-amyloid (Aβ), tau, snRNP70 (U1-70K), and apolipoprotein E (APOE) in the sarkosyl-insoluble fractions of AD brain compared to those of control, consistent with previous tissue fractionation strategies. Thus, this simple enrichment protocol is ideal for a wide range of experimental applications ranging from Western blotting and functional protein co-aggregation assays to mass spectrometry-based proteomics.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29155708      PMCID: PMC5755167          DOI: 10.3791/55835

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  24 in total

Review 1.  The amyloid beta peptide: a chemist's perspective. Role in Alzheimer's and fibrillization.

Authors:  I W Hamley
Journal:  Chem Rev       Date:  2012-07-19       Impact factor: 60.622

2.  Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis.

Authors:  Manuela Neumann; Deepak M Sampathu; Linda K Kwong; Adam C Truax; Matthew C Micsenyi; Thomas T Chou; Jennifer Bruce; Theresa Schuck; Murray Grossman; Christopher M Clark; Leo F McCluskey; Bruce L Miller; Eliezer Masliah; Ian R Mackenzie; Howard Feldman; Wolfgang Feiden; Hans A Kretzschmar; John Q Trojanowski; Virginia M-Y Lee
Journal:  Science       Date:  2006-10-06       Impact factor: 47.728

3.  Phosphorylated alpha-synuclein is ubiquitinated in alpha-synucleinopathy lesions.

Authors:  Masato Hasegawa; Hideo Fujiwara; Takashi Nonaka; Koichi Wakabayashi; Hitoshi Takahashi; Virginia M-Y Lee; John Q Trojanowski; David Mann; Takeshi Iwatsubo
Journal:  J Biol Chem       Date:  2002-10-10       Impact factor: 5.157

4.  Alzheimer's beta-amyloid protein is covalently modified when dissolved in formic acid.

Authors:  W E Klunk; J W Pettegrew
Journal:  J Neurochem       Date:  1990-06       Impact factor: 5.372

5.  Conformational change, aggregation and fibril formation induced by detergent treatments of cellular prion protein.

Authors:  L W Xiong; L D Raymond; S F Hayes; G J Raymond; B Caughey
Journal:  J Neurochem       Date:  2001-11       Impact factor: 5.372

Review 6.  Protein aggregation and neurodegenerative disease.

Authors:  Christopher A Ross; Michelle A Poirier
Journal:  Nat Med       Date:  2004-07       Impact factor: 53.440

7.  Measurement of protein using bicinchoninic acid.

Authors:  P K Smith; R I Krohn; G T Hermanson; A K Mallia; F H Gartner; M D Provenzano; E K Fujimoto; N M Goeke; B J Olson; D C Klenk
Journal:  Anal Biochem       Date:  1985-10       Impact factor: 3.365

8.  Proteomics analysis reveals novel components in the detergent-insoluble subproteome in Alzheimer's disease.

Authors:  Yair M Gozal; Duc M Duong; Marla Gearing; Dongmei Cheng; John J Hanfelt; Christopher Funderburk; Junmin Peng; James J Lah; Allan I Levey
Journal:  J Proteome Res       Date:  2009-11       Impact factor: 4.466

9.  Proteomic screening for amyloid proteins.

Authors:  Anton A Nizhnikov; Alexander I Alexandrov; Tatyana A Ryzhova; Olga V Mitkevich; Alexander A Dergalev; Michael D Ter-Avanesyan; Alexey P Galkin
Journal:  PLoS One       Date:  2014-12-30       Impact factor: 3.240

10.  Unique pathological tau conformers from Alzheimer's brains transmit tau pathology in nontransgenic mice.

Authors:  Jing L Guo; Sneha Narasimhan; Lakshmi Changolkar; Zhuohao He; Anna Stieber; Bin Zhang; Ronald J Gathagan; Michiyo Iba; Jennifer D McBride; John Q Trojanowski; Virginia M Y Lee
Journal:  J Exp Med       Date:  2016-10-17       Impact factor: 14.307

View more
  14 in total

1.  Altered Developmental Trajectory in Male and Female Rats in a Prenatal Valproic Acid Exposure Model of Autism Spectrum Disorder.

Authors:  Kumari Anshu; Ajay Kumar Nair; Shoba Srinath; T Rao Laxmi
Journal:  J Autism Dev Disord       Date:  2022-08-17

2.  Truncated Tau caused by intron retention is enriched in Alzheimer's disease cortex and exhibits altered biochemical properties.

Authors:  Zhen-Kai Ngian; Yow-Yong Tan; Ching-Thong Choo; Wei-Qi Lin; Chao-Yong Leow; Shan-Jie Mah; Mitchell Kim-Peng Lai; Christopher Li-Hsian Chen; Chin-Tong Ong
Journal:  Proc Natl Acad Sci U S A       Date:  2022-09-06       Impact factor: 12.779

3.  HS3ST2 expression induces the cell autonomous aggregation of tau.

Authors:  M B Huynh; N Rebergue; H Merrick; W Gomez-Henao; E Jospin; D S F Biard; D Papy-Garcia
Journal:  Sci Rep       Date:  2022-06-27       Impact factor: 4.996

4.  Tau aggregates are RNA-protein assemblies that mislocalize multiple nuclear speckle components.

Authors:  Evan Lester; Felicia K Ooi; Nadine Bakkar; Jacob Ayers; Amanda L Woerman; Joshua Wheeler; Robert Bowser; George A Carlson; Stanley B Prusiner; Roy Parker
Journal:  Neuron       Date:  2021-04-12       Impact factor: 17.173

5.  Apolipoprotein E Proteinopathy Is a Major Dementia-Associated Pathologic Biomarker in Individuals with or without the APOE Epsilon 4 Allele.

Authors:  Jozsef Gal; Yuriko Katsumata; Haining Zhu; Sukanya Srinivasan; Jing Chen; Lance Allen Johnson; Wang-Xia Wang; Lesley Renee Golden; Donna M Wilcock; Gregory A Jicha; Matthew D Cykowski; Peter Tobias Nelson
Journal:  Am J Pathol       Date:  2021-12-24       Impact factor: 4.307

6.  ApoE4 activates C/EBPβ/δ-secretase with 27-hydroxycholesterol, driving the pathogenesis of Alzheimer's disease.

Authors:  Zhi-Hao Wang; Yiyuan Xia; Pai Liu; Xia Liu; Laura Edgington-Mitchell; Kecheng Lei; Shan Ping Yu; Xiao-Chuan Wang; Keqiang Ye
Journal:  Prog Neurobiol       Date:  2021-03-11       Impact factor: 10.885

7.  Quantitative proteomic analysis of the frontal cortex in Alzheimer's disease.

Authors:  Gajanan Sathe; Marilyn Albert; Jacqueline Darrow; Atsushi Saito; Juan Troncoso; Akhilesh Pandey; Abhay Moghekar
Journal:  J Neurochem       Date:  2020-07-22       Impact factor: 5.546

8.  Human amyloid-β enriched extracts: evaluation of in vitro and in vivo internalization and molecular characterization.

Authors:  Cristina M Pedrero-Prieto; Alicia Flores-Cuadrado; Daniel Saiz-Sánchez; Isabel Úbeda-Bañón; Javier Frontiñán-Rubio; Francisco J Alcaín; Lourdes Mateos-Hernández; José de la Fuente; Mario Durán-Prado; Margarita Villar; Alino Martínez-Marcos; Juan R Peinado
Journal:  Alzheimers Res Ther       Date:  2019-06-29       Impact factor: 6.982

Review 9.  Accumulation of "Old Proteins" and the Critical Need for MS-based Protein Turnover Measurements in Aging and Longevity.

Authors:  Nathan Basisty; Anja Holtz; Birgit Schilling
Journal:  Proteomics       Date:  2019-09-10       Impact factor: 3.984

10.  G protein-coupled receptor kinases are associated with Alzheimer's disease pathology.

Authors:  Thais Rafael Guimarães; Eric Swanson; Julia Kofler; Amantha Thathiah
Journal:  Neuropathol Appl Neurobiol       Date:  2021-07-19       Impact factor: 8.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.